Ticker brief
NUVB
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
14
authors 14d
10
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-06-22 → 2026-06-30 · now +0.40 (−1 bearish … +1 bullish)
Who spoke10
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @fundmyfund | B | -2.01 | 2 | +0.50 |
| @ABBONews | C | · | 2 | -0.20 |
| @CrweWorld | C | · | 2 | +0.12 |
| @PersimmonTI | A | -0.32 | 2 | +0.50 |
| @Sir_Kory | C | +1.61 | 1 | +0.25 |
| @Maximus_Holla | C | -0.48 | 1 | +0.50 |
| @zohmbastic | C | -1.00 | 1 | +0.25 |
| @OpenOutcrier | C | · | 1 | -0.30 |
| @OzmosiHealth | C | · | 1 | +0.45 |
| @PrismMarketView | C | · | 1 | +0.45 |
Recent signals14of 14 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-06-30 | @PersimmonTI | +0.40 | Frames recent biotech financings as misunderstood good entry points. | · | tweet ↗ |
| 2026-06-29 | @PrismMarketView | +0.45 | UK MHRA validated partner Eisai's Marketing Authorisation Application for taletrectinib. | · | tweet ↗ |
| 2026-06-29 | @OzmosiHealth | +0.45 | Nuvation announces UK marketing authorization application validated for taletrectinib. | · | tweet ↗ |
| 2026-06-29 | @CrweWorld | +0.40 | UK marketing authorization application for taletrectinib is validated. | · | tweet ↗ |
| 2026-06-27 | @PersimmonTI | +0.60 | Calls NUVB and BBIO convertible note offerings bullish long-term and shareholder aligned. | · | tweet ↗ |
| 2026-06-26 | @ABBONews | -0.20 | Nuvation priced upsized $250M convertible senior notes due 2032. | · | tweet ↗ |
| 2026-06-26 | @CrweWorld | -0.15 | Nuvation Bio prices upsized $250M convertible senior notes offering. | · | tweet ↗ |
| 2026-06-25 | @ABBONews | -0.20 | Nuvation announces plan for $200M convertible senior notes due 2032. | · | tweet ↗ |
| 2026-06-25 | @OpenOutcrier | -0.30 | Nuvation Bio plans $200M convertible notes offering due 2032; down premarket. | · | tweet ↗ |
| 2026-06-24 | @zohmbastic | +0.25 | Positive end-of-day comment on NUVB. | · | tweet ↗ |
| 2026-06-24 | @fundmyfund | +0.55 | Calls NUVB a top idea coming into week with strong technical setup. | · | tweet ↗ |
| 2026-06-24 | @Maximus_Holla | +0.50 | Author reports 50% gain on NUVB. | · | tweet ↗ |
| 2026-06-22 | @fundmyfund | +0.45 | Wanted to enter NUVB after chart review but says it jumped on biotech M&A fervor. | · | tweet ↗ |
| 2026-06-22 | @Sir_Kory | +0.25 | Notes NUVB steady climb with chart link. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.